Showing results (61-70 of 308) with videos related to
Sort By:
Pageof 31
International Journal of Radiation Oncology, Biology, Physics|August 1, 1986
A method for the combined measurement of ethiofos and WR-1065 in plasma: application to pharmacokinetic experiments with ethiofos and its metabolitesN F Swynnerton, B K Huelle, D J Mangold, et al.Therapeutic Drug Monitoring|January 1, 1985
Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluationJ M Svec, R W Coleman, D R Mungall, et al.Pharmaceutical Research|July 1, 1996
Bioequivalence: individual and population compartmental modeling compared to the noncompartmental approachH S Pentikis, J D Henderson, N L Tran, et al.Clinical Pharmacokinetics|June 1, 1992
Pharmacokinetics of quinidine in male patients. A population analysisC N Verme, T M Ludden, W A Clementi, et al.Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1989
Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects modelsM S Driscoll, T M Ludden, D T Casto, et al.Clinical Pharmacy|July 1, 1986
Evaluation of a Bayesian regression-analysis computer program for predicting phenytoin concentrationT M Ludden, S L Beal, C C Peck, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1978
Brain and plasma concentrations of amphetamine isomers in miceW H Riffee, T M Ludden, R E Wilcox, et al.Therapeutic Drug Monitoring|March 1, 1991
Sensitivity analysis of the effect of bioavailability or dosage form content on mean steady state phenytoin concentrationT M Ludden, S R Allerheiligen, T R Browne, et al.Investigational New Drugs|January 1, 1983
Characterization of the pharmacokinetics of bisantrene (NSC-337766)J G Kuhn, T M Ludden, J W Myers, et al.Social Science & Medicine (1982)|January 1, 1982
Population genetic models in the study of aging and longevity in a Mennonite communityM H Crawford, L RogersPageof 31